The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
COSTEM 2019 | CARs: driving the field forward
Michael Bishop, MD, University of Chicago Medical Center, Chicago, IL, discusses the CAR-T research he is most excited about, where the field is likely to move, and the prospect of CAR-T becoming a globally used therapy, replacing more conventional therapies. This interview took place at the 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.
